<DOC>
	<DOCNO>NCT00644943</DOCNO>
	<brief_summary>The primary objective compare safety efficacy cefdinir oral suspension , 7 mg/kg/day ql2hrs 5 day , amoxicillin/clavulanate oral suspension 45 mg/kg/day ( base amoxicillin component ) , divide dos , q12h 10 day , child 6 month 6 year age , AOM .</brief_summary>
	<brief_title>A Comparison Safety Efficacy Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate Pediatric Subjects With Acute Otitis Media</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Cefdinir</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Clinical diagnosis , document medical history physical examination , acute otitis medium &lt; =1 week Clinical sign symptom include &gt; =1 following : ear pain ; ear fullness , decrease hearing , discharge external auditory canal ( follow acute perforation tympanic membrane ) . At least two follow condition present least one ear : bulging tympanic membrane , may redness ; loss normal light reflex tympanic membrane landmark abnormal tympanic membrane mobility biphasic pneumatic otoscopy , due presence pu fluid behind edema tympanic membrane . Have evidence middle ear fluid demonstrate acoustic reflecttympometry . Generally good health base medical history , vital sign , physical exam , historical laboratory result Previous enrollment study . Enrollment investigational study use unapproved product unapproved dos , include investigational vaccine previous four week prior study start . Hypersensitivity reaction cefdinir , cephalosporin , penicillin , drug , and/or sensitivity multiple allergen . Presence tympanostomy tube otitis externa Evaluation 1 . Systemic treatment antiinfective agent within 7 day ( 14 day azithromycin ) prior Evaluation 1 study . Treatment longacting injectable antimicrobial agent ( e.g. , penicillin G benzathine ) within 4 week prior study drug administration . Concomitant infection , require additional antimicrobial therapy . Evidence chronic , suppurative otitis medium . Evidence physiologic , anatomic , immunologic defect , would interfere resolution episode acute otitis medium . Presence disease , complicate factor ( e.g. , mastoiditis ) , structural abnormality would preclude evaluation subject 's therapeutic response . Known , severe renal impairment ( i.e. , creatinine clearance &lt; 30 mUmid1.73 m2 ) . History Augmentinassociated cholestatic jaundicehepatic dysfunction .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>